These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transdermally administered scopolamine vs. dimenhydrinate. II. Effect on different types of nystagmus. Pyykkö I, Schalén L, Matsuoka I. Acta Otolaryngol; 1985; 99(5-6):597-604. PubMed ID: 4024910 [Abstract] [Full Text] [Related]
5. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea. Noy S, Shapira S, Zilbiger A, Ribak J. Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687 [Abstract] [Full Text] [Related]
9. Comparison of efficacy dimenhydrinate and metoclopramide in the treatment of nausea due to vertigo; a randomized study. Ercin D, Erdur B, Turkcuer I, Seyit M, Ozen M, Yilmaz A, Zincir Ercin DO. Am J Emerg Med; 2021 Feb; 40():77-82. PubMed ID: 33360021 [Abstract] [Full Text] [Related]
16. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action]. Wang E. Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342 [Abstract] [Full Text] [Related]